Still relying on cold-chain qPCR workflows? Traditional qPCR mixes depend on refrigerated storage and shipping—raising costs, complicating logistics, and slowing scale-up. As workflows expand, this dependency is becoming harder to sustain. Our NEW Liquid Ambient-Stable DNA qPCR Mixes deliver true ambient stability for 12 months, maintaining performance in a liquid format with no need for lyophilization or air-drying. Choose the format that fits your development needs: 🔹 MDX360 – Liquid Stable Flex DNA qPCR Mix – Add primers/probes at the point of use for full customization; ideal for low–high throughput and assay optimization. 🔹 MDX364 – Liquid Stable Ready DNA qPCR Mix – A fixed, ready-to-run format with primers/probes added during manufacturing; engineered for scalable, repeatable production. Whether you’re building customizable workflows or fixed high-throughput assays, these mixes reduce cost and complexity—without compromising performance. Explore performance data/compare formats: hubs.la/Q04kB52f0 Contact a specialist/request a sample: hubs.la/Q04kDFHB0 #qPCRmastermixes #MolecularDiagnostics #AssayDevelopment #LifeSciences #PrecisionDiagnostics #NextGenDiagnostics #LiquidStableqPCR #AmbientStability #DiagnosticInnovation #ambientstableassay

Point-of-care diagnostics are transforming how and where testing happens—but challenges around enzyme stability, cost, and logistics can slow adoption. View our on-demand featured presentation "Empowering Molecular Point-of-Care Diagnostics with Ambient-Stable Chemistries" with William Ferreira, R&D Team Leader at Meridian Life Science. Explore how established and emerging molecular techniques—including qPCR, isothermal amplification, and NGS—can be adapted with ambient-stable reagent chemistries to enable faster, more scalable, and cost-effective testing at the point of care. Learn how Meridian’s technologies support: • Molecular point-of-care testing • Ambient-stable, cold-chain-free chemistries • Infectious disease diagnostics • Decentralized and near-patient testing • Rapid assay development in resource-limited settings ▶️ Watch now: hubs.la/Q04ksgrl0 Contact a specialist for more: hubs.la/Q04ks2010 #PointOfCareDiagnostics #MolecularDiagnostics #AmbientStable #ColdChainFree #DecentralizedTesting #InfectiousDisease #AssayDevelopment #LifeScienceInnovation #POCT #EnzymeStability

Last chance to gain practical insight into GPCR signaling with proven, high performance assays. Webinar, June 9, 11:00 AM ET / 8:00 AM PT. ms.spr.ly/6013vkQVZ GPCR signaling remains complex, and generating reliable data is critical for drug discovery success. Join our experts for this final opportunity to explore industry leading GPCR assays that support every stage of signal transduction—from ligand binding and G protein activation to arrestin recruitment, downstream signaling, and receptor internalization. Discover how modern, high throughput immunoassays can streamline assay development and deliver high quality results for even the most challenging GPCR targets. #GPCR #DrugDiscovery #LifeSciences #AssayDevelopment

#Flow over to Booth #612 at #CYTO2026 where we have some cool #swag for you to take home! And don’t miss our research on novel #Standards for #Calibration: 👉 P017 – Novel Particulate Matrix for Flow Cytometric Discovery and Diagnostic Workflows Kathryn Kilbride, Jason Streit Ph.D., James Dobscha Ph.D., Jennifer Tullman Ph.D. ✨ Monday, June 8, 5 – 7 pm, Hall AB ✨ 👉 P144 – Flexible, Low-Autofluorescence Calibration Standard for Conventional and Spectral Analyzers Kathryn Kilbride, Jason Streit Ph.D., James Dobscha Ph.D., Jennifer Tullman Ph.D. Tuesday, June 9, 5 – 7 pm, Hall AB #FlowCytometry #AssayDevelopment #Assays #Cytometry #Fluorescent

📊 Engineering better PETases isn’t just a modeling problem, it’s a data problem. In the PETase Engineering Tournament, we partnered to develop three independent assay platforms to measure expression and activity across temperature and pH: cell-free systems, E. coli Rapid Fire Mass Spec, and microfluidic droplets. The takeaways: → High-throughput ≠ high-quality → Realistic assays ≠ scalable assays → Generating reliable, ML-ready data is still the bottleneck Though challenging, this is the kind of groundwork needed to actually move the field forward. 🔗Full methods learnings: hubs.ly/Q04dFDg00 💪 Many thanks to our sponsor Twist Bioscience for DNA synthesis and to Adaptyv for their valuable collaboration on assay development. #ProteinEngineering #SyntheticBiology #EnzymeEngineering #MachineLearning #Biotech #AssayDevelopment #DataScience #Bioengineering #Sustainability #PlasticRecycling

#VAL ValiRx CEO Mark Eccleston to attend the Cambridge Healthtech Institute PepTalk meeting on 19-22 January in San Diego, representing ValiRx, but also its subsidiaries Inaphaea BioLabs, Cytolytix and Blue Ribbon Bio. The meeting is focused on Protein Science and production and includes streams on peptide drug hunting, peptide targets and peptide therapeutics, providing an excellent opportunity to discuss the CLX001 oncolytic peptide program as well as Val201 2.0. If you're attending the meeting and would like to meet with Mark to speak about our services and expertise, please connect with Mark directly or contact us here: lnkd.in/ecZxReTD #CHIPepTalk #Assays #AssayDevelopment #BioTech #DrugDiscovery #CancerResearch #ScientificResearch #Event #Networking

#VAL 👇 ValiRx CEO Mark Eccleston is attending several events as part of JP Morgan Week in San Francisco from 11-15 January, representing ValiRx, but also its subsidiaries Inaphaea BioLabs, Cytolytix and Blue Ribbon Bio.   You can find Mark at: - The J.P. Morgan Global Healthcare Conference - The Informa Connect Biotech Showcase event   Those interested in arranging a meeting can connect with Mark via the partneringONE platform associated with the Biotech Showcase, or contact us here: lnkd.in/ecZxReTD   For those unable to meet in San Francisco, Mark will also be attending the Cambridge Healthtech Institute PepTalk meeting in San Diego the following week.   #JPM26 #BiotechShowcase #Assays #AssayDevelopment #BioTech #DrugDiscovery #CancerResearch #ScientificResearch #Event #Networking

#VAL 👇 ValiRx CEO Mark Eccleston is attending several events as part of JP Morgan Week in San Francisco from 11-15 January, representing ValiRx, but also its subsidiaries Inaphaea BioLabs, Cytolytix and Blue Ribbon Bio.   You can find Mark at: - The J.P. Morgan Global Healthcare Conference - The Informa Connect Biotech Showcase event   Those interested in arranging a meeting can connect with Mark via the partneringONE platform associated with the Biotech Showcase, or contact us here: lnkd.in/ecZxReTD   For those unable to meet in San Francisco, Mark will also be attending the Cambridge Healthtech Institute PepTalk meeting in San Diego the following week.   #JPM26 #BiotechShowcase #Assays #AssayDevelopment #BioTech #DrugDiscovery #CancerResearch #ScientificResearch #Event #Networking

Choosing the right CDMO is key for assay development success. With a track record developing & manufacturing life-changing diagnostic assays, we deliver tailored, innovative solutions through a problem-solving culture 📲 tinyurl.com/4bczb6hr #AssayDevelopment #LifeSciences

#VAL 👇 ValiRx CEO Mark Eccleston is attending several events as part of JP Morgan Week in San Francisco from 11-15 January, representing ValiRx, but also its subsidiaries Inaphaea BioLabs, Cytolytix and Blue Ribbon Bio.   You can find Mark at: - The J.P. Morgan Global Healthcare Conference - The Informa Connect Biotech Showcase event   Those interested in arranging a meeting can connect with Mark via the partneringONE platform associated with the Biotech Showcase, or contact us here: lnkd.in/ecZxReTD   For those unable to meet in San Francisco, Mark will also be attending the Cambridge Healthtech Institute PepTalk meeting in San Diego the following week.   #JPM26 #BiotechShowcase #Assays #AssayDevelopment #BioTech #DrugDiscovery #CancerResearch #ScientificResearch #Event #Networking

Potency and Cell-Based Assay Center Opened by Avance Biosciences The Center supports clients across the development and manufacturing of biologics, RNA therapeutics, vaccines, and cell and gene therapies @AvanceBio #mAb #assaydevelopment #biomanufacturing hubs.li/Q03X2B1-0

Postdoc — Protein Biochemistry for Structural Biology (Loerch Lab, UC Santa UCSC See the full job description on jobRxiv: jobrxiv.org/job/ucsc-27778-p… #AssayDevelopment #Biochemicalanalysis #biochemistry #proteinpurification #ScienceJobs jobrxiv.org/job/ucsc-27778-p…

Transferring a lyophilised assay from development to manufacturing involves several key considerations: ⚙️ Freeze dryer capabilities 🧪 Formulations ✅ Validations 🔬 Quality control Learn more 👉 bit.ly/3XAm5s2 #Lyophilisation #AssayDevelopment #ScaleUp

We’re live at #AMPath2025 in Boston! Stop by Booth #1115 to meet the Meridian Life Science team and see how our next-generation molecular reagents are helping labs move beyond cold-chain limits and streamline molecular workflows. Discover how our ambient-temperature stabilization technologies enable reliable, scalable solutions — from point-of-care to high-throughput molecular testing. We’d love to connect while you’re here! Schedule a meeting: hubs.la/Q03T202z0 Get more event details: hubs.la/Q03T22KK0 #AMP2025 #MolecularDiagnostics #AmbientStable #nextgensequencing #DiagnosticsInnovation #SustainableScience #AssayDevelopment @AMPath

Revolutionising diagnostics with LAMP assays! 🔬 LAMP is a robust, versatile alternative to traditional PCR, simplifying workflows & creating opportunities for accurate, affordable diagnostics away from the lab 📲 tinyurl.com/hw2dyja7 #LAMP #AssayDevelopment #Diagnostics

Is rigid manufacturing stifling your innovation? Flexible contract manufacturing at Biofortuna can help you tackle setup costs and unpredictable demand. Check out our case studies: bit.ly/4nWpz3l #assaydevelopment #lyophilization #IVD #cdmo

🔬 Meet iconPCR: Unlock full DOE flexibility and cut PCR assay development time in half—with 96 independent wells, scale smarter & get better data! Discover how: news-medical.net/whitepaper/… #PCR #AssayDevelopment

Did you know lyophilising your assays can simplify logistics? It extends shelf life & eliminates cold chain logistics. We help companies break free from cold chain, bringing products to market efficiently 👉 tinyurl.com/y8bwjj3e #ColdChain #Lyophilisation #AssayDevelopment

Lyophilisation requires know-how and resource. Partnering with us provides both. We remove the barriers to product development so you can bring your lyophilised assay to market quickly and efficiently 📲 bit.ly/4lnZyIM #AssayDevelopment #Lyophilisation #CDMO

Heading to #ADLM2025? Pop by Booth 4339 to see how we'veve helped IVD developers across the globe solve problems & achieve their goals. It all starts with a conversation - bit.ly/4nxfCdj #assaydevelopment #moleculardiagnostics #lyophilization #contractmanufacturing